Nadia Tenenbaum

Long-term Safety of Rivastigmine in Parkinson Disease Dementia

Murat Emre, Werner Poewe, Peter Paul De Deyn et al. · Clinical Neuropharmacology · 2014 · 74 citations

Medicine, Pharmacology, Pharmacotherapy +17

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials

Xavier Montalbán, Patrick Vermersch, Douglas L. Arnold et al. · The Lancet Neurology · 2024 · 72 citations

Life Sciences, Neurology, Pharmacotherapy +6

Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results

Jeffrey A. Cohen, Nadia Tenenbaum, Alit Bhatt et al. · Therapeutic Advances in Neurological Disorders · 2019 · 71 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +11

Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study

Shuu‐Jiun Wang, Artemio Roxas, B. Saravia et al. · Cephalalgia · 2021 · 65 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Long-term Efficacy and Safety of Erenumab

Peter J. Goadsby, Uwe Reuter, Michel Lantéri‐Minet et al. · Neurology · 2021 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14